US Retail Sales Stagnate in December Missing Growth Expectations JPMorgan Chase Declares 150 Quarterly Dividend Extending Payout Streak Nvidia Stock Approaches Critical Technical Level as Market Awaits Direction Plus500 Reports 11 Quarterly Revenue Increase Maintains FullYear Outlook Amazoncoms Unwavering Grip on Wall Street Why Analysts Remain Focused Page Industries Reports Strong Top Line Growth as Revenue from Operations and Sales Volume Increase MasTec Inc MTZ Q1 2026 Earnings EPS Surges 3893 Above Estimates Despite Stock Decline SBCF Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations BankUnited BKU Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Potential Underlying Strength LCI Industries Q1 2026 Earnings EPS Surprises by 157 as Shares Rise Biglari Holdings BH Q1 2025 Earnings Strong EPS Amid Quiet Market Reception Seabridge Gold SA Q1 2024 Earnings DevelopmentStage Miner Posts Net Loss No Revenue as KSM Project Advances Bonk Inc BNKK Slides 556 as Bearish Pressure Intensifies Near Key Support DTW Inches Higher Amid FixedIncome Stability Debenture Holds Steady at 2116 Trinity Industries TRN Under Pressure Stock Declines 461 as Key Support Nears Sturm Ruger RGR Holds Steady at 3961 Consolidation in a Defensive Sector Unifi Inc UFI Edges Higher as Stock Tests Key Support Level Near 392 UDR Q1 2026 Earnings Massive EPS Beat of 413 Surprises Analysts FNLC Q1 2026 Earnings EPS of 080 Reported Stock Edges Up Amid Sparse Disclosure SPIR Q1 2026 Earnings EPS Misses Estimates as Stock Surges 1224 HTB Q1 2026 Earnings EPS Surpasses Estimates by 1994 ORC Q1 2026 Earnings Strong EPS Beat Amid Stock Decline US Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience CCB Q1 2026 Earnings EPS Falls 261 Below Estimates Lexicon Pharmaceuticals LXRX Slides 314 as Shares Test NearTerm Support Levels Renasant Q1 2026 Earnings EPS Surpasses Estimates as Shares Edge Lower Hawaiian Electric Industries Q1 2026 Earnings EPS Falls Short of Estimates Amid Ongoing Challenges CRBP Q1 2026 Earnings Narrower Loss Beats Estimates but No Revenue and Sharp Share Decline Raise Concerns BCAL Q1 2026 Earnings EPS Surpasses Estimates by 276 LCNB Q1 2026 Earnings EPS Misses Estimates by 132 FLR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Edges Higher Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress